Below the Belt Award

Penile cancer is a rare disease that affects approximately 1 in 100,000 men in Western countries. Despite its rarity, penile cancer can have a significant impact on patients’ quality of life and is associated with high rates of morbidity and mortality. Currently, there is a lack of comprehensive data on the risk factors and management of penile cancer in Australia. To address this gap in knowledge, we are proposing the establishment of an Australian Penile Cancer Registry. The aim of this registry is to establish a database that can clarify local risk factors and assess the effectiveness of current treatments in managing penile cancer. This will be built upon an existing Victorian database with globally significant retrospective series and a proven publication record. As a national registry it will overcome barriers to access for interdisciplinary work and have a wider lens with more significant impact. One of the key objectives of this registry is to improve our understanding of penile cancer, including its underlying biology and patterns of disease. By collecting and analysing data on patient demographics, tumour characteristics, and treatment outcomes, we hope to identify factors that may contribute to the development and progression of penile cancer. In addition to providing valuable insights into the biology of penile cancer, the registry has the potential to inform clinical practice and improve patient outcomes. By evaluating the effectiveness of current treatments, we can identify areas for improvement and develop more targeted and effective therapies. In conclusion, the establishment of an Australian Penile Cancer Registry has the potential to make a significant contribution to the field of penile cancer research. By improving our understanding of penile cancer risk factors and management, we can ultimately improve outcomes for patients and reduce the burden of this disease on individuals and broader society.